Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
Personalized medicine: CCO's vision, accomplishments and future plans
Jennifer Guo1, Suzanne Kamel-Reid2, Michael Rutherford3
1Policy Research Analyst, Pathology and Laboratory Medicine Program at Cancer Care Ontario.
Abstract:
Personalized medicine is a rapidly expanding field, with the potential to improve patient care. Its benefits include increasing efficiency in cancer screening, diagnosis and treatment through early detection, targeted therapy and identifying individuals with an underlying genetic risk for cancer or adverse outcomes. Through the work of Cancer Care Ontario (CCO)'s Pathology and Laboratory Medicine Program, a number of initiatives have been undertaken to support developments in personalized medicine. In keeping with the momentum of recent accomplishments, CCO has led the formation of the Personalized Medicine Steering Committee to develop a comprehensive provincial genetics strategy for the future of cancer care.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Patient-centered Care
Purpose of Health Records II
Purpose of Health Records I
Here's a breakdown of how health records serve these purposes:
Targeted Cancer Therapies
There are several types of targeted therapies against...

